Novo Nordisk A/S (NYSE:NVO) is investigating claims by cyber extortion group FulcrumSec, which alleges it stole more than a terabyte of data from the pharmaceutical company and is considering selling portions of the information after an unsuccessful $25 million ransom demand.
FulcrumSec Claims Months-Long Access To Company Systems Citing a message posted by FulcrumSec on Tuesday, Reuters reported that the group spent more than two months inside Novo Nordisk's networks collecting data.
The hackers claimed the stolen information includes source code, proprietary details related to marketed and unreleased drugs, clinical trial information, employee, physician, and patient data, details concerning production facilities, and information tied to the company's internal artificial intelligence models.
Read Also: iRhythm Investigates Cyber Incident After Hackers Claim Access To Sensitive Data Novo Nordisk acknowledged the allegations in a statement provided to Reuters.
The company said it is aware of claims that data allegedly copied from its systems without authorization has been published online.
